Cerecin: Funding, Investors & Team (Sep 2026)
Cerecin is a healthcare company that develops novel evidence-based therapeutics and products that aim to help people. Cerecin develops novel evidence-based therapeutics and products that aim to help millions of people. These solutions are designed to target conditions ranging from memory impairment to Alzheimer’s disease and other devastating neurological diseases. The company was founded in 2001 and is based in Denver, Colorado.
Cerecin has raised $46.7M across 3 funding rounds on record, the most recent an undisclosed round of $7.2M announced in Aug 2022.
That round is in line with the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Cerecin Company Profile and Key Stats
Latest funding round on record: Aug 2022.
Cerecin Funding Rounds
Cerecin raised $10.0M in an undisclosed round announced in Feb 2021.
8 months later, a Series A of $29.5M was announced in Oct 2021.
10 months later, an undisclosed round of $7.2M was announced in Aug 2022.
Cerecin Founders and Leadership Team
Contact details for the Cerecin team: 1 of 1 has an email address on file.
Start 14-day free trial →Cerecin Funding Compared to Other Biotechnology Startups
Cerecin's latest round of $7.2M is in line with the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Cerecin in Biotechnology and Denver
Companies Similar to Cerecin
SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory…
DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer…
Solstice Oncology is a clinical stage immuno-oncology company
Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad…
BrainChild Bio is a biotechnology company in the clinical stage that specializes in pediatric brain tumors.…
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Cerecin Funding FAQs
What does Cerecin do?
Cerecin is a healthcare company that develops novel evidence-based therapeutics and products that aim to help people. Cerecin develops novel evidence-based therapeutics and products that aim to help millions of people. These solutions are designed to target conditions ranging from memory impairment to Alzheimer’s disease and other devastating neurological diseases. The company was founded in 2001 and is based in Denver, Colorado.
How much funding has Cerecin raised?
Cerecin has raised $46.7M across 3 rounds on record. The most recent is an undisclosed round of $7.2M announced in Aug 2022.
When did Cerecin last raise funding?
Cerecin's most recent funding round on record is an undisclosed round of $7.2M, announced in Aug 2022.
Who is the CEO of Cerecin?
Charles Stacey is listed as CEO at Cerecin.
Where is Cerecin headquartered?
Cerecin is based in Denver, Colorado, United States.
How many employees does Cerecin have?
Cerecin is in the 11-50 employee band.
How does Cerecin's funding compare to other Biotechnology startups?
Cerecin's latest round of $7.2M is in line with the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.
About FundedIQ's Cerecin Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Cerecin is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.